Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
20+ years of experience in pharmaceutical R&D with extensive leadership experience in exploratoryâfull development and regulatory across a range of therapeutic areas. Expert in all stage of drug development from discovery to post registration. Fully experienced with big pharma and start-up
He has gathered, through various roles of increasing responsibilities (Medicinal Chemistry Head, Global Project Director, VP non clinical and manufacturing and head of R&D) a strong expertise in drug development by managing various research and preclinical/early/late stage drugs development programs, and cross-functional international development project teams in the area of neurology, autoimmune disorders, endocrinology, fertility, metabolism and oncology. He has developed a deep operational and strategic knowledge and expertise in drug development through the management of various drug development functions
Neurology, autoimmune disorders, endocrinology, fertility, metabolism and oncology.
Oliver Pohl, John Kendrick and Jean-Pierre Gotteland
Research Article: J Bioequiv Availab 2013, 5: 177-184